INMUNE BIO INC. - COMMON STOCK
5.4900
10-January-25 16:45:00
15 minutes delayed
Stocks
+0.1900
+3.58%
Today's range
5.1500 - 5.6650
ISIN
N/A
Source
NASDAQ
-
07 May 2024 08:00:01 By Nasdaq GlobeNewswire
-
30 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
25 Apr 2024 09:00:00 By Nasdaq GlobeNewswire
-
23 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
08 Apr 2024 08:00:01 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
28 Mar 2024 16:01:53 By Nasdaq GlobeNewswire
-
26 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
13 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
05 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
12 Feb 2024 09:00:00 By Nasdaq GlobeNewswire
-
INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
06 Feb 2024 09:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
30 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
02 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
18 Dec 2023 16:01:00 By Nasdaq GlobeNewswire
-
27 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe
15 Nov 2023 09:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update
01 Nov 2023 16:10:41 By Nasdaq GlobeNewswire